Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ·Healthcare·Biotechnology
$2.20
-3.51%
Mkt Cap $4.93M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 20, 2026 | $3.00K | $3.00K | +0.00% | -$0.37 | -$0.80 | -116.22% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | -$0.48 | -$0.48 | +0.00% | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | -$0.63 | -$0.48 | +23.81% | — | — |
| Q2 2025 May 9, 2025 | — | $3.00K | — | -$0.52 | -$0.83 | -59.62% | — | — |
| Q1 2025 Mar 14, 2025 | — | $3.00K | — | -$0.63 | -$1.12 | -77.78% | — | — |
| Q4 2024 Nov 8, 2024 | — | — | — | -$0.85 | -$0.75 | +11.76% | — | — |
| Q3 2024 Aug 9, 2024 | — | $8.00K | — | -$0.84 | -$1.11 | -32.14% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$1.15 | -$0.73 | +36.52% | — | — |
| Q1 2024 Mar 22, 2024 | — | $3.00K | — | -$1.13 | -$1.21 | -7.08% | — | — |
| Q4 2023 Nov 14, 2023 | — | $6.00K | — | -$0.86 | -$1.02 | -18.60% | — | — |
| Q3 2023 Aug 11, 2023 | $10.00K | — | — | -$0.83 | -$0.78 | +6.02% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$1.00 | -$0.70 | +30.00% | — | — |
| Q1 2023 Mar 31, 2023 | $300.00K | $18.60K | -93.80% | -$0.70 | -$0.53 | +24.29% | — | — |
| Q4 2022 Nov 10, 2022 | $110.00K | $55.00K | -50.00% | -$0.13 | -$0.07 | +46.15% | — | — |
| Q3 2022 Aug 12, 2022 | $100.00K | $10.00K | -90.00% | -$0.15 | -$0.20 | -33.33% | — | — |
| Q2 2022 May 13, 2022 | $15.00K | $15.00K | +0.00% | -$0.14 | -$0.18 | -28.57% | — | — |
| Q1 2022 Mar 30, 2022 | — | $67.75K | — | -$0.23 | -$4.16 | -1708.70% | — | — |
| Q4 2021 Dec 6, 2021 | — | $10.00K | — | — | -$7.52 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | $10.00K | — | — | -$12.52 | — | — | — |
| Q2 2021 May 17, 2021 | — | — | — | — | $111.83 | — | — | — |